{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChange": -0.049999952, "regularMarketTime": 1683875702, "regularMarketDayHigh": 1.58, "regularMarketDayRange": "1.58 - 1.58", "regularMarketDayLow": 1.58, "regularMarketVolume": 1500, "regularMarketPreviousClose": 1.63, "bid": 1.57, "ask": 1.73, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.58, "averageDailyVolume3Month": 25, "averageDailyVolume10Day": 151, "fiftyTwoWeekLowChange": 0.04000008, "fiftyTwoWeekLowChangePercent": 0.02597408, "fiftyTwoWeekRange": "1.54 - 13.5", "fiftyTwoWeekHighChange": -11.92, "fiftyTwoWeekHighChangePercent": -0.88296294, "fiftyTwoWeekLow": 1.54, "fiftyTwoWeekHigh": 13.5, "exchange": "FRA", "shortName": "BIOND.PHAR.ADS/400 IL-01", "longName": "BiondVax Pharmaceuticals Ltd.", "messageBoardId": "finmb_9300995", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -3.0674818, "regularMarketPrice": 1.58, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.67, "sharesOutstanding": 3284060, "bookValue": -0.536, "fiftyDayAverage": 1.8326, "fiftyDayAverageChange": -0.25259995, "fiftyDayAverageChangePercent": -0.13783693, "twoHundredDayAverage": 5.701255, "twoHundredDayAverageChange": -4.121255, "twoHundredDayAverageChangePercent": -0.722868, "marketCap": 5403995, "priceToBook": -2.9477613, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1525672800000, "priceHint": 4, "symbol": "2F50.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Jerusalem BioPark Building", "address2": "2nd floor Hadassah Ein Kerem Campus", "city": "Jerusalem", "country": "Israel", "phone": "972 8 930 2529", "fax": "972 8 930 2531", "website": "https://www.biondvax.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center G\u00f6ttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  Reichman M.B.A., M.Sc.", "age": 46, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 562497, "fmt": "562.5k", "longFmt": "562,497"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Elad  Mark B.Sc., Eng., M.B.A.", "age": 40, "title": "Chief Operating Officer", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": {"raw": 277016, "fmt": "277.02k", "longFmt": "277,016"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tamar  Ben-Yedidia Ph.D.", "age": 58, "title": "Chief Science Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 314924, "fmt": "314.92k", "longFmt": "314,924"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Uri  Ben-Or CPA, CPA, M.B.A., MBA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joshua E. Phillipson B.Sc., M.B.A.", "title": "Director of Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Moran Ahdout Fruchter L.L.B.", "title": "Chief of Staff", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Dalit Weinstein Fischer", "title": "VP and Head of Technical R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}